Sionna Therapeutics

We are a life sciences company that is building on over a decade of extensive research on the genetic mutations associated with cystic fibrosis. We are developing first-in-class small molecules that are focused on a unique target with the potential to fully normalize CFTR function for the first time for the vast majority of people living with CF

Life sciences,biotechnology,pharmaceuticals,cystic fibrosis,protein function,genetics,genetic mutation,genetic disease,clinical research,clinical study,research,small molecule,molecular engineering,chemistry,patient advocacy,drug development,clinical development,lung,orphan disease,and rare disease

Sionna therapeutics operates in the Biotechnology industry.

Sionna therapeutics's revenue is 11m - 100m

Sionna therapeutics has 11 - 50 employees.